| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Institute of Bone and Joint Research, Department of Public Health, ANZAC Research Institute, University of Sydney, Prince of Wales Medical Research Institute, Sydney, New South Wales 2065, Australia
Address all correspondence and requests for reprints to: Prof. Philip Sambrook, Institute of Bone and Joint Research, Royal North Shore Hospital, St. Leonards, New South Wales 2065, Australia. E-mail: sambrook{at}med.usyd.edu.au.
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Although much of the focus on biochemical aspects of falls risk has concentrated on vitamin D, there are data supporting an independent effect of PTH on muscle. For example, muscle biopsies obtained in patients suffering from primary hyperparathyroidism have demonstrated type II muscle fiber atrophy (12). In addition, PTH increases proteolysis of muscle proteins and thereby augments the liberation of the amino acids, alanine and glutamine (13). Treatment with PTH has been shown to reduce the intracellular content of inorganic phosphate and calcium-adenosine triphosphatase in rat muscle cells (14), and mRNA for the PTH/PTH-related peptide receptor has been founded in rat muscle tissue (15).
There have been few prospective studies of the relationship among vitamin D status, PTH, and falls. In this study we measured serum 25-hydroxyvitamin D (25OHD), PTH, and objective measures of risk of falls at baseline in a frail elderly institutionalized population and their relationship to falls assessed prospectively.
| Subjects and Methods |
|---|
|
|
|---|
Older people residing in intermediate-care hostels and nursing homes in northern Sydney, Australia, were visited and invited to participate. Individuals who were bed-bound, bilateral amputees, non-English speaking, or under the age of 65 yr were not included in the study, but significant comorbidity was not an exclusion criteria. Eligible residents gave informed consent or, if unable, their next of kin gave proxy consent. Ethics approval was given by the institutional human research ethics committee. Institutions were visited in random order, and in total, 2005 residents were recruited. The participation rate of eligible residents was 55% (self consent, 77%; proxy, 33%). The study is referred to as the FREE study (Fracture Risk Epidemiology in the Elderly) (16, 17). This report is restricted to those participants who were ambulatory and required low care, and comprises data for 646 subjects who had completed at least 3 months of follow-up and for whom baseline serum vitamin D and PTH measurements were available. There were no differences between participants and nonparticipants in gender, age, and type of institution or in time living there (all P > 0.15). The mean duration of follow-up was 10.2 months (the 25th percentile was 7.2 months and the 75th percentile was 12 months).
Clinical biochemistry
At the time of measurement of falls risk, a blood sample for measurement of serum 25OHD and PTH was collected. Specimens for this study were stored as aliquots immediately after centrifugation at 40 C, and only a single freeze-thaw cycle was involved before assay. Serum 25OHD was measured using a specific RIA after an initial extraction kit (DiaSorin, Inc., Stillwater, MN). The assay has a sensitivity of 4 nmol/liter, with an intraassay precision of 7.6% and an interassay precision of 9.0%. The laboratory reference range is 39140 nmol/liter.
Serum levels of intact PTH were determined by a two-site chemiluminescent ELISA on an Immulite 1000 analyzer (Diagnostic Products, Los Angeles, CA). The assay procedure measures the intact PTH molecule. The sensitivity of this assay is 1 pg/ml, and cross-reactivity to PTH fragments and related compounds is low. The assay has a typical intraassay precision of 5.5%, an interassay precision of 7.9%, and the laboratory reference range is 2366 pg/ml.
Serum calcium was measured by colorimetric assay (Roche, Indianapolis, IN) using p-cresolphthalein and adjusted for circulating albumin levels, with a normal range 2.152.55 mmol/liter. A modified Jaffé (picric acid) kinetic colorimetric assay was used to measure serum creatinine, with a normal range in males of 70110 µmol/liter and in females of 5090 µmol/liter. Inorganic phosphorus levels were measured by an end-point method with sample blanking, based on the formation of ammonium phosphomolybdate complex. The normal range in this laboratory is 0.61.3 mmol/liter. Serum albumin was measured by a BCG colorimetric assay (Roche), with a normal range of 4050 g/liter. Measurements of serum calcium, creatinine, inorganic phosphorus, and albumin were only available in a subsample of 264 subjects.
Clinical risk factors
Clinical risk factors were assessed in all subjects at interview, including age, sex, weight, height, presence or absence of incontinence, and medication use. The level of care was ascertained from the Resident Classification Scale (RCS), an eight-point classification instrument that determines the level of government subsidy for each resident. It is based on care need and is weighted for behavioral changes associated with dementia (18). Illness severity was assessed using a modification of the Implicit Illness Severity Scale, in which residents were classified on a four-point scale, where 1 indicated no symptoms, 2 indicated mild symptoms or conditions, 3 indicated moderate symptoms or conditions, and 4 indicated seriously ill (19). Cognitive status was assessed with the Standardized Mini Mental Status Examination (SMMSE) (20).
Standing balance was assessed using the static balance test (5), simplified for this population with a high prevalence of instability by removing the eyes-closed standing conditions. Subjects were classified into five grades: grade 1, unable to stand on the floor for any period without support from another person or use of a walking aid; grade 2, unable to maintain balance on the floor for 30 sec; grade 3, capable of maintaining balance on the floor for 30 sec, but unable to maintain balance on a compliant foam rubber mat (70 x 60 x 15 cm thick) for any period of time; grade 4, capable of maintaining balance on the floor, but unable to maintain balance on the foam rubber mat for 30 sec; and grade 5, capable of maintaining balance when standing on the floor and the foam mat for 30-sec periods. Postural sway (5) was also assessed while subjects underwent the static balance test. Visual contrast sensitivity was assessed using the Melbourne Edge Test (21). Proprioception was measured using a lower limb-matching task (5). Knee extension strength was measured isometrically with subjects seated and the angles of the hip and knee joints positioned at 90° (5). Reaction time was assessed using a light as the stimulus and a finger-press as the response (5). Finally, the subjects sit-to-stand ability was measured by assessing their ability to rise from a standard height (0.43 m) chair with armrests (22). Subjects were graded on a four-point scale, where grade 1 indicated capable without the need for arm support, grade 2 indicated capable with the use of the arms, grade 3 indicated capable with the help of another person, and grade 4 indicated incapable. The reliability of these tests has been established in previous studies (21, 22, 23). Fifty-six subjects did not undergo the sit-to-stand test, as this test was not introduced until shortly after the commencement of the study.
Statistical analysis
As a high degree of care provided by nursing staff might influence fall results in subjects with high RCS grades, all analyses were limited to subjects with RCS above 4 (low care). The data were censored at 1 yr. Comparisons between fallers and nonfallers were made with two sample tests. Serum PTH was transformed to a normal distribution using the natural logarithm. Partial correlations were used to determine an association between two variables while adjusting for other variables. Cox proportional hazards models were used to calculate and determine relations between PTH, 25OHD, and time to first fall while adjusting for potential confounders. Interactions between PTH, 25OHD, and other variables were tested in models. In all analyses a value of P < 0.05 (two-tailed) was considered significant.
| Results |
|---|
|
|
|---|
|
|
90 yr). For those who were less than 90 yr old, in a multivariate analysis that included PTH, 25OHD, balance, SMMSE, incontinence, and implicit illness severity, PTH (HR, 1.43; 95% CI, 1.121.82; P = 0.004), balance (P < 0.001), SMMSE (P = 0.04), incontinence (P = 0.01), and illness severity (P = 0.02) remained significant predictors, but 25OHD did not (P = 0.62; Table 3
|
| Discussion |
|---|
|
|
|---|
This is the first large prospective study to observe a relationship between falls and serum PTH. In a prior retrospective cross-sectional study of 83 residents of nursing home and intermediate-care hostels living in Melbourne, Australia, higher serum PTH was independently associated with falling (11). The median age of that population was 84 yr, and most were vitamin D deficient, with a median serum 25OHD level of 27 nmol/liter. Residents who fell (n = 33) had both lower serum 25OHD levels and higher serum PTH levels, but in a multiple logistic regression, serum PTH remained independently associated with falling [odds ratio (OR), 5.6; 95% CI, 1.718.5] per unit of the natural logarithm of serum PTH. Other significant predictors were hostel accommodation (OR, 0.04; 95% CI, 0.010.25) and ability to walk without aids (OR, 0.07; 95% CI, 0.010.37).
The relationship we observed among PTH, 25OHD, and objective measures of falls risk are of interest in terms of the potential mechanism of PTH-mediated falls risk. The inverse correlations we observed between PTH and quadriceps strength and rising from a chair may suggest that the effect of PTH is mediated by diminished muscle function. In a prospective cross-sectional study (10), 60 patients were recruited from a falls clinic and stratified according to serum 25OHD: group 1, 25OHD below 30 nmol/liter; group 2, 25OHD between 3042.5 30 nmol/liter; and group 3, 25OHD above 42.5 nmol/liter. Twenty healthy elderly volunteers with 25OHD above 42.5 nmol/liter comprised group 4. Group 1 had the greatest degree of postural sway and the weakest quadriceps strength, although this did not reach significance. Multivariate analysis revealed 25OHD as an independent variable for postural sway, but PTH was an independent variable associated with muscle strength, with fallers having higher PTH values. In a prospectively randomized, placebo-controlled trial in vitamin D-deficient older women (mean serum 25OHD, 23 nmol/liter), short-term supplementation with vitamin D and calcium decreased plasma PTH by 18% (P = 0.04) and body sway by 9% (P = 0.04), while there was a 50% reduction in falls (P = 0.03), compared with the placebo group (24).
Vitamin D was not significantly associated with falls after correcting for age, incontinence, and illness severity in this study (P = 0.06). However, a relationship between 25OHD and balance was observed. A number of previous studies have found a relationship between serum 25OHD and falls (8, 9, 10, 25) and between vitamin D and neuromuscular function (8, 9, 10). In contrast, low serum vitamin D levels did not predict new onset of disability or loss of muscle strength in older women in an observational study (26). However, vitamin D deficiency is only one factor contributing to muscle weakness in the elderly (27, 28). The effect of 25OHD on falls via effects on neuromuscular function may be obscured by a high level of chronic illness, medication use, and cognitive disorders in this population. In a recent large prospective study (25), a low level of serum vitamin D was independently associated with time to first fall, but the association was not apparent in nursing home residents, and serum PTH was not measured. In our study we observed that the subjects with low 25OHD land elevated PTH levels were 65% more likely to have a fall than those whose 25OHD and PTH levels were in the normal range. In contrast, those participants with either low 25OHD or high PTH levels did not have a significantly elevated risk of falling.
This study has certain strengths and limitations. The inclusion of nursing home and intermediate-care residents allowed examination of falls in a high risk cohort, but the findings may not be generalizable to more able elderly subjects. Moreover, as serum 25OHD and PTH are closely related, it may be difficult to completely separate the effects of elevated serum PTH from low serum 25OHD on falls, even with sophisticated statistical analyses.
In summary, serum PTH seems to be an independent predictor of time to first fall in the frail elderly. However, the relationship between serum PTH, independent of vitamin D status, and a number of measures of general health on falls risk observed in this study suggests that the biochemical mechanisms associated with secondary hyperparathyroidism and muscle are complex and require further investigation.
| Footnotes |
|---|
Received October 13, 2003.
Accepted January 15, 2004.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
P. Leventis and S. Patel Clinical aspects of vitamin D in the management of rheumatoid arthritis Rheumatology, November 1, 2008; 47(11): 1617 - 1621. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Gallagher, P. B. Rapuri, and L. M. Smith An Age-Related Decrease in Creatinine Clearance Is Associated with an Increase in Number of Falls in Untreated Women But Not in Women Receiving Calcitriol Treatment J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 51 - 58. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Snijder, N. M. van Schoor, S. M. F. Pluijm, R. M. van Dam, M. Visser, and P. Lips Vitamin D Status in Relation to One-Year Risk of Recurrent Falling in Older Men and Women J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2980 - 2985. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.M. Francis, F.H. Anderson, S. Patel, O. Sahota, and T.P. van Staa Calcium and vitamin D in the prevention of osteoporotic fractures QJM, June 1, 2006; 99(6): 355 - 363. [Full Text] [PDF] |
||||
![]() |
M. F. Holick High Prevalence of Vitamin D Inadequacy and Implications for Health Mayo Clin. Proc., March 1, 2006; 81(3): 353 - 373. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. N. Sambrook, J. S. Chen, L. M. March, I. D. Cameron, R. G. Cumming, S. R. Lord, J. Schwarz, and M. J. Seibel Serum Parathyroid Hormone Is Associated with Increased Mortality Independent of 25-Hydroxy Vitamin D Status, Bone Mass, and Renal Function in the Frail and Very Old: A Cohort Study J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5477 - 5481. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |